Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 11/20 | 0.36 |
| ▸ | F13A1 | P00488 | 7/20 | 0.36 |
| ▸ | TGM1 | P22735 | 7/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.30 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28988331 | 1.00 | — | — | |
| SCHEMBL27091885 | 0.93 | TSHR (0.38) | TSHRALDH1A1MAPK1TDP1CA12 | |
| SCHEMBL26690315 | 0.90 | — | — | |
| SCHEMBL1337362 | 0.90 | TGM2 (0.42) | TSHRALDH1A1MAPK1TDP1CA12 | |
| SCHEMBL2733784 | 0.89 | CA12 (0.53) | MAPK1CA12CA2CA9MEN1 | |
| SCHEMBL615220 | 0.88 | HTT (0.41) | TSHRALDH1A1MAPK1TDP1TGM2 | |
| SCHEMBL3753325 | 0.84 | TGM2 (0.45) | TSHRALDH1A1MAPK1TDP1CA12 | |
| SCHEMBL1147261 | 0.84 | CA12 (0.45) | ALDH1A1CA12CA2CA9MEN1 | |
| SCHEMBL9420528 | 0.84 | TSHR (0.33) | TSHRALDH1A1MAPK1TDP1TGM2 | |
| SCHEMBL4120737 | 0.84 | TSHR (0.40) | TSHRALDH1A1MAPK1TDP1TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4124331-A1 | AESTHETIC DENTAL FILLING MATERIAL WITH HIGH CURING DEPTH | Ivoclar Vivadent AG (LI) | 2023-02-01 | — | — | EP | claimed |
| EP-2277496-B1 | Dental material containing surface-modified fillers | IVOCLAR VIVADENT AG (LI) | 2016-03-30 | — | — | EP | claimed |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230100885-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-03-30 | — | — | US | disclosed |
| US-11576845-B2 | Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-02-14 | — | — | US | disclosed |
| US-20210032578-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2021-02-04 | — | — | US | disclosed |
| EP-3013146-B1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | 3M INNOVATIVE PROPERTIES CO (US) | 2020-11-25 | — | — | EP | disclosed |
| US-10844337-B2 | Wipe with a guanidinyl-containing polymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-11-24 | — | — | US | disclosed |
| EP-3565522-A1 | METHODS OF REMOVING SPORES | 3M Innovative Properties Company (US) | 2019-11-13 | — | — | EP | disclosed |
| EP-3565411-A1 | METHODS OF REMOVING SPORES | 3M Innovative Properties Company (US) | 2019-11-13 | — | — | EP | disclosed |
| US-20190336409-A1 | METHODS OF REMOVING SPORES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-07 | — | — | US | disclosed |
| US-5756742-A | Polymerizable compounds | HENKEL CORPORATION (US) | 1998-05-26 | — | — | US | disclosed |
| WO-1998009994-A1 | ADHESIVES FOR FLEXIBLE LAMINATES | HENKEL CORPORATION (US) | 1998-03-12 | — | — | WO | disclosed |
| US-5719202-A | Polymerizable N,N'-substituted piperazine acrylamide compounds | HENKEL CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| WO-1997023562-A1 | POLYMERIZABLE COMPOUNDS | HENKEL CORPORATION (US) | 1997-07-03 | — | — | WO | disclosed |
| EP-0723542-A4 | POLYMERIZABLE COMPOUNDS | HENKEL CORP (US) | 1996-10-23 | — | — | EP | disclosed |
| US-5565567-A | Polymerizable N,N'-substituted piperazine acrylamide compounds | HENKEL CORPORATION. (US) | 1996-10-15 | — | — | US | disclosed |
| US-5563214-A | Aqueous compositions containing polymerizable surfactant compounds | HENKEL CORPORATION (US) | 1996-10-08 | — | — | US | disclosed |
| EP-0723542-A1 | POLYMERIZABLE COMPOUNDS | HENKEL CORPORATION (US) | 1996-07-31 | — | — | EP | disclosed |
| WO-1994029296-A1 | POLYMERIZABLE COMPOUNDS | HENKEL CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844337-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885 |
| US-11576845-B2 | Methods of removing spores comprising alcohol, acrylate copolymer particles, and a cationic coated article | ACR, CUTA, PRKDC | TSHR 2090/4885ALDH1A1 1340/4885MAPK1 2722/4885 |
| US-20190336409-A1 | METHODS OF REMOVING SPORES | CUTA, ACR, PRF1 | TSHR 1949/4885ALDH1A1 1251/4885MAPK1 3568/4885 |
| US-20210032578-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | GNPDA1, GDA, PGLS | TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885 |
| US-11827864-B2 | Wipe with a guanidinyl-containing polymer | GNPDA1, GDA, PGLS | TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885 |
| US-20230100885-A1 | WIPE WITH A GUANIDINYL-CONTAINING POLYMER | GNPDA1, GDA, PGLS | TSHR 4391/4885ALDH1A1 4262/4885MAPK1 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.